Tegge Jonathan 4
4 · InMed Pharmaceuticals Inc. · Filed Dec 26, 2023
Insider Transaction Report
Form 4
Tegge Jonathan
Interim CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-12-23+30,000→ 31,400 totalExercise: $0.37Exp: 2028-12-22→ Common shares (30,000 underlying)
Footnotes (1)
- [F1]The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month).